PREVENTION AND TREATMENT STRATEGIES FOR RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA-ASSOCIATED SQUAMOUS CELL CARCINOMA

$1,728,281FY2018Defense Health AgencyDOD

Thomas Jefferson University, Philadelphia PA

Investigators